Radhakrishnan Maha — SEC Form 4 filings

SEC reporting owner CIK 2013423. 5 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-03-12 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Alto Neuroscience, Inc. (ANRO)Director12
Candel Therapeutics, Inc. (CADL)Director22
Entrada Therapeutics, Inc. (TRDA)Director22

Form 4 filings — Radhakrishnan Maha

FiledFormIssuerReported transactionsSource
2026-06-244Candel Therapeutics, Inc. (CADL)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2026-06-124Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2025-06-064Candel Therapeutics, Inc. (CADL)Grant/award (A): 28,480 (derivative) @ $0EDGAR
2025-06-034Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 38,000 (derivative) @ $0EDGAR
2024-03-124Alto Neuroscience, Inc. (ANRO)Grant/award (A): 30,574 (derivative) @ $0 · Grant/award (A): 1,590 (derivative) @ $10.21EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2013423 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →